Combined tipranavir and enfuvirtide use associated with higher plasma tipranavir concentrations but not with increased hepatotoxicity: sub-analysis from RESIST
(Q58389005)
article
article
Language:
Current Data About
Combined tipranavir and enfuvirtide use associated with higher plasma tipranavir concentrations but not with increased hepatotoxicity: sub-analysis from RESIST
| (P31) |
(Q13442814)
|
||||||||||||||
| (P50) |
(Q40213049)
(Q62559552)
|
||||||||||||||
| (P304) |
1977-1980
|
||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||
| (P433) |
14
|
||||||||||||||
| (P478) |
21
|
||||||||||||||
| (P577) |
+2007-09-00T00:00:00Z
|
||||||||||||||
| (P921) |
(Q1349821)
|
||||||||||||||
| (P1104) |
4
|
||||||||||||||
| (P1433) |
(Q4651863)
|
||||||||||||||
| (P1476) |
"Combined tipranavir and enfuvirtide use associated with higher plasma tipranavir concentrations but not with increased hepatotoxicity: sub-analysis from RESIST" (language: en)
|
||||||||||||||
| (P2093) |
Fran??ois Raffi
Milos Opravil
Gary Blick
Roy T Steigbigel
Michael Kraft
Dietmar Neubacher
John P Sabo
|
other details